Gabapentin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 76420-497
  • Package NDC 76420-497-01
  • Package NDC 76420-497-05
  • Package NDC 76420-497-12
  • Package NDC 76420-497-24
  • Package NDC 76420-497-30
  • Package NDC 76420-497-60
  • Package NDC 76420-497-90
  • Application number ANDA205101
  • SPL ID eaa81374-5d2c-60d1-e053-2a95a90af8ea
  • SPL set ID 9d544944-ea95-42e1-8c65-9e442437f0ee
  • UNII 6CW7F3G59X
  • RxCUI 310434

What the source publishes

Labeler
Asclemed USA, Inc.
Active ingredients
Gabapentin
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:76420-497_eaa81374-5d2c-60d1-e053-2a95a90af8ea
{
  "name": "Gabapentin",
  "splId": "eaa81374-5d2c-60d1-e053-2a95a90af8ea",
  "labels": [
    {
      "setId": "9d544944-ea95-42e1-8c65-9e442437f0ee",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d544944-ea95-42e1-8c65-9e442437f0ee",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9d544944-ea95-42e1-8c65-9e442437f0ee"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Asclemed USA, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (76420-497-01)",
      "package_ndc": "76420-497-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    },
    {
      "sample": false,
      "description": "500 TABLET in 1 BOTTLE (76420-497-05)",
      "package_ndc": "76420-497-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    },
    {
      "sample": false,
      "description": "120 TABLET in 1 BOTTLE (76420-497-12)",
      "package_ndc": "76420-497-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    },
    {
      "sample": false,
      "description": "240 TABLET in 1 BOTTLE (76420-497-24)",
      "package_ndc": "76420-497-24",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    },
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (76420-497-30)",
      "package_ndc": "76420-497-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    },
    {
      "sample": false,
      "description": "60 TABLET in 1 BOTTLE (76420-497-60)",
      "package_ndc": "76420-497-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (76420-497-90)",
      "package_ndc": "76420-497-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221010"
    }
  ],
  "productId": "76420-497_eaa81374-5d2c-60d1-e053-2a95a90af8ea",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "76420-497",
  "deaSchedule": null,
  "genericName": "Gabapentin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GABAPENTIN",
      "strength": "800 mg/1"
    }
  ],
  "applicationNumber": "ANDA205101",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160204",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486"
    ],
    "unii": [
      "6CW7F3G59X"
    ],
    "rxcui": [
      "310434"
    ],
    "spl_set_id": [
      "9d544944-ea95-42e1-8c65-9e442437f0ee"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "manufacturer_name": [
      "Asclemed USA, Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:76420-497_eaa81374-5d2c-60d1-e053-2a95a90af8ea"